Corcept Therapeutics
CORT
CORT
135 hedge funds and large institutions have $387M invested in Corcept Therapeutics in 2016 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
27% more capital invested
Capital invested by funds: $305M → $387M (+$82.6M)
23% more funds holding
Funds holding: 110 → 135 (+25)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
135
Holding in Top 10
2
Calls
$1.43M
Puts
$545K
Top Buyers
| 1 | +$8.87M | |
| 2 | +$6.88M | |
| 3 | +$4.58M | |
| 4 |
Two Sigma Investments
New York
|
+$2.86M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$2.41M |
Top Sellers
| 1 | -$3.34M | |
| 2 | -$3.27M | |
| 3 | -$2.18M | |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$1.25M |
| 5 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$979K |